Vyne Therapeutics (VYNE) has had the highest return between August 17, 2025 and August 17, 2026 by a US stock in the Biotechnology Industry, returning 780,669.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vyne Therapeutics (VYNE) | 8/17/2025 - 8/17/2026 | 780,669.23% |
Aptorum Group Ltd Class A (APM) | 8/17/2025 - 8/17/2026 | 600,614.29% |
Seaport Therapeutics, Inc Common Stock (SPTX) | 8/17/2025 - 8/17/2026 | 242,100% |
Erasca (ERAS) | 8/17/2025 - 8/17/2026 | 1,101.31% |
Damora Therapeutics (DMRA) | 8/17/2025 - 8/17/2026 | 843.47% |
Climb Bio (CLYM) | 8/17/2025 - 8/17/2026 | 728.93% |
Sellas Life Sciences (SLS) | 8/17/2025 - 8/17/2026 | 679.27% |
Praxis Precision Medicines (PRAX) | 8/17/2025 - 8/17/2026 | 677.8% |
Q32 Bio (QTTB) | 8/17/2025 - 8/17/2026 | 665.15% |
Shattuck Labs (STTK) | 8/17/2025 - 8/17/2026 | 657.14% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 8/17/2025 - 8/17/2026 | 652.84% |
Oruka Therapeutics (ORKA) | 8/17/2025 - 8/17/2026 | 611.79% |
Prelude Therapeutics (PRLD) | 8/17/2025 - 8/17/2026 | 538.15% |
Forte Biosciences (FBRX) | 8/17/2025 - 8/17/2026 | 533.13% |
Spyre Therapeutics (SYRE) | 8/17/2025 - 8/17/2026 | 511.39% |
Relay Therapeutics (RLAY) | 8/17/2025 - 8/17/2026 | 461.02% |
Dianthus Therapeutics (DNTH) | 8/17/2025 - 8/17/2026 | 459.92% |
Revolution Medicines (RVMD) | 8/17/2025 - 8/17/2026 | 458.26% |
AN2 Therapeutics (ANTX) | 8/17/2025 - 8/17/2026 | 454.63% |
Alumis (ALMS) | 8/17/2025 - 8/17/2026 | 433.97% |
Immix Biopharma (IMMX) | 8/17/2025 - 8/17/2026 | 383.26% |
MBX Biosciences, Inc Common Stock (MBX) | 8/17/2025 - 8/17/2026 | 369.98% |
Nanobiotix (NBTX) | 8/17/2025 - 8/17/2026 | 341.87% |
AnaptysBio (ANAB) | 8/17/2025 - 8/17/2026 | 335.91% |
Apollomics Inc Class A Ordinary Shares (APLM) | 8/17/2025 - 8/17/2026 | 334.94% |